Wu Jiaxiang, Ding Ping'an, Wu Haotian, Yang Peigang, Guo Honghai, Tian Yuan, Meng Lingjiao, Zhao Qun
The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Hebei Key Laboratory of Precision Diagnosis and Comprehensive Treatment of Gastric Cancer, Shijiazhuang, China.
Front Nutr. 2023 Feb 2;10:1037200. doi: 10.3389/fnut.2023.1037200. eCollection 2023.
Skeletal muscle is the foundation of human function and plays a key role in producing exercise, bone protection, and energy metabolism. Sarcopenia is a systemic disease, which is characterized by degenerative changes in skeletal muscle mass, strength, and function. Therefore, sarcopenia often causes weakness, prolonged hospitalization, falls and other adverse consequences that reduce the quality of life, and even lead to death. In recent years, sarcopenia has become the focus of in-depth research. Researchers have suggested some molecular mechanisms for sarcopenia according to different muscle physiology. These mechanisms cover neuromuscular junction lesion, imbalance of protein synthesis and breakdown, satellite cells dysfunction, etc. We summarize the latest research progress on the molecular mechanism of sarcopenia in this review in order to provide new ideas for future researchers to find valuable therapeutic targets and develop relevant prevention strategies.
骨骼肌是人体功能的基础,在产生运动、保护骨骼和能量代谢中起关键作用。肌肉减少症是一种全身性疾病,其特征是骨骼肌质量、力量和功能发生退行性变化。因此,肌肉减少症常导致虚弱、住院时间延长、跌倒等不良后果,降低生活质量,甚至导致死亡。近年来,肌肉减少症已成为深入研究的焦点。研究人员根据不同的肌肉生理学提出了一些肌肉减少症的分子机制。这些机制包括神经肌肉接头病变、蛋白质合成与分解失衡、卫星细胞功能障碍等。我们在本综述中总结了肌肉减少症分子机制的最新研究进展,以便为未来的研究人员寻找有价值的治疗靶点和制定相关预防策略提供新思路。